Clinical Trial

REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients

Study acronym: RESONANCE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The registry will focus on furthering the understanding of the natural history of recurrent pericarditis (RP), as well as document RP-related clinical, health-related quality of life (HRQoL), and economic burden and will assist the medical community to refine or develop data-driven recommendations for clinical management of RP patients to optimize clinical outcomes. It also aims to generate data in support of the impact of rilonacept on clinical outcomes in a real-world population.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2020-12-23; most recent amendment 2026-02-13.
Status change: Recruiting → Active, Not Recruiting 2025-04-25
Status change: Not Yet Recruiting → Recruiting 2021-05-06
Trial Details
NCT Number NCT04687358
Lead Sponsor Kiniksa Pharmaceuticals International, plc
Collaborators: Kiniksa Pharmaceuticals (UK), Ltd.
Conditions Recurrent Pericarditis
Enrollment 500 participants
Start Date 2021-03-16
Primary Completion 2029-03 (estimated)
Study Completion 2029-03 (estimated)
Updated on ClinicalTrials.gov 2026-02-17